[HTML][HTML] Nanoparticles for targeted brain drug delivery: what do we know?
RGR Pinheiro, AJ Coutinho, M Pinheiro… - International Journal of …, 2021 - mdpi.com
The blood–brain barrier (BBB) is a barrier that separates the blood from the brain tissue and
possesses unique characteristics that make the delivery of drugs to the brain a great …
possesses unique characteristics that make the delivery of drugs to the brain a great …
Drug targeting to the brain
AG De Boer, PJ Gaillard - Annu. Rev. Pharmacol. Toxicol., 2007 - annualreviews.org
The central nervous system (CNS) is a sanctuary site and is protected by various barriers.
These regulate brain homeostasis and the transport of endogenous and exogenous …
These regulate brain homeostasis and the transport of endogenous and exogenous …
Peptide mediated brain delivery of nano-and submicroparticles: a synergistic approach
M McCully, M Sanchez-Navarro… - Current …, 2018 - ingentaconnect.com
The brain is a complex, regulated organ with a highly controlled access mechanism: The
Blood-Brain Barrier (BBB). The selectivity of this barrier is a double-edged sword, being both …
Blood-Brain Barrier (BBB). The selectivity of this barrier is a double-edged sword, being both …
The route of nanomaterials entering brain
Y Liu, Q He - Neurotoxicity of Nanomaterials and Nanomedicine, 2017 - Elsevier
The blood–brain barrier (BBB) provides a stable and safe environment for physiological
function of the central nervous system (CNS) as a protective barrier. However, the existence …
function of the central nervous system (CNS) as a protective barrier. However, the existence …
Drug delivery to the brain across the blood–brain barrier using nanomaterials
A major obstacle facing brain diseases such as Alzheimer's disease, multiple sclerosis,
brain tumors, and strokes is the blood–brain barrier (BBB). The BBB prevents the passage of …
brain tumors, and strokes is the blood–brain barrier (BBB). The BBB prevents the passage of …
[HTML][HTML] Peptide based drug delivery systems to the brain
With estimated worldwide cost over $1 trillion just for dementia, diseases of the central
nervous system pose a major problem to health and healthcare systems, with significant …
nervous system pose a major problem to health and healthcare systems, with significant …
[HTML][HTML] Blood-brain barrier and delivery of protein and gene therapeutics to brain
WM Pardridge - Frontiers in aging neuroscience, 2020 - frontiersin.org
Alzheimer's disease (AD) and treatment of the brain in aging require the development of
new biologic drugs, such as recombinant proteins or gene therapies. Biologics are large …
new biologic drugs, such as recombinant proteins or gene therapies. Biologics are large …
[HTML][HTML] Targeted drug delivery to the central nervous system using extracellular vesicles
The blood brain barrier (BBB) maintains the homeostasis of the central nervous system
(CNS) and protects the brain from toxic substances present in the circulating blood …
(CNS) and protects the brain from toxic substances present in the circulating blood …
Delivery of peptide and protein drugs over the blood–brain barrier
I Brasnjevic, HWM Steinbusch, C Schmitz… - Progress in …, 2009 - Elsevier
Peptide and protein (P/P) drugs have been identified as showing great promises for the
treatment of various neurodegenerative diseases. A major challenge in this regard …
treatment of various neurodegenerative diseases. A major challenge in this regard …
Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier
G Sharma, AR Sharma, SS Lee, M Bhattacharya… - International journal of …, 2019 - Elsevier
The blood brain barrier (BBB) offers protection to the central nervous system (CNS) by
maintaining homeostasis. Besides restricting the entry of harmful xenobiotics and …
maintaining homeostasis. Besides restricting the entry of harmful xenobiotics and …